A Steady Run That’s Closing in on a Notable Horror Benchmark
Lee Cronin’s The Mummy has settled into a steady, if unspectacular, pattern in North America. After six days on release, the Lee Cronin horror movie had collected USD 17.1 million (approx. RM80 million) domestically, holding on to the third spot on the charts despite not gaining fresh momentum. Its immediate target is a very specific benchmark: surpassing the domestic total of 28 Years Later: The Bone Temple, which finished with USD 25.1 million (approx. RM118 million). The Mummy is now less than USD 10 million (approx. RM47 million) away from overtaking that film’s haul, a milestone that may not impress on paper but does matter within horror film earnings. Beating a recent franchise sequel that underperformed would signal that The Mummy has avoided the bottom tier of recent genre outings and secured a respectable foothold in the marketplace.
Dropping Below USD 1 Million: What the First Wednesday Means
The clearest sign that The Mummy’s peak run is behind it came on its very first Wednesday. The film slipped below the USD 1 million (approx. RM5 million) mark, grossing USD 901,000 (approx. RM4.2 million) on that day and falling 43.2% from its first discounted Tuesday. For studios and analysts, crossing under USD 1 million this quickly usually indicates that front‑loaded demand is easing and that a film is transitioning from hot opening title to mid‑run performer. Yet this does not automatically spell trouble for overall profitability. Horror films often have modest budgets and can still hit solid margins through consistent weekday business, premium formats, and eventual digital and streaming windows. The key question now is how sharply The Mummy continues to decline once new competition, including Michael, further erodes its hold on genre audiences in theatres.
How The Mummy’s Legs Compare in a Crowded Horror Landscape
Within the broader 2026 slate of genre releases, The Mummy’s trajectory underscores how fragile horror box office legs can be. 28 Years Later: The Bone Temple, despite positive reviews and the halo of 28 Years Later, still struggled to convert buzz into sustained ticket sales, ultimately topping out at USD 25.1 million (approx. RM118 million) domestically. The Mummy’s push to clear that figure highlights the importance of word of mouth and repeat viewings in modern horror. Strong openings remain driven by marketing and brand recognition, but long‑term earnings depend on audiences convincing friends that a film is worth the trip, and on viewers returning for second or third showings. With new genre titles arriving quickly, any dip in enthusiasm can shorten the window dramatically. The Mummy’s current run suggests it has found a decent, if not breakout, level of audience support.
Mummy 4’s New Date and What It Says About Franchise Confidence
While The Mummy navigates its theatrical slowdown, Universal has quietly reshaped the series’ future. The next The Mummy sequel, an untitled fourth entry from Radio Silence filmmakers Matt Bettinelli‑Olpin and Tyler Gillett, has shifted to an October 15, 2027 release date. The move comes as Miami Vice ’85, starring Michael B. Jordan and Austin Butler, takes over The Mummy’s previous slot. Crucially, Mummy 4 will bring back Brendan Fraser and Rachel Weisz as Rick and Evelyn O’Connell, signalling that the studio still sees long‑term value in the brand. Positioning the film in October suggests a targeted horror corridor strategy, aligning with seasonal audience appetite. The shuffle also gives more breathing room for development and post‑production, hinting that Universal wants to get this chapter right rather than rushing to capitalise solely on The Mummy box office momentum of the current film.
Can The Mummy’s Current Arc Support an Expanded Universe?
With The Mummy edging toward a domestic total that could surpass 28 Years Later: The Bone Temple, the franchise sits at a crossroads. On one hand, the film’s steady but unspectacular horror film earnings suggest there is still an audience for supernatural adventure‑horror, especially when anchored by recognisable branding. On the other, the early drop below USD 1 million (approx. RM5 million) midweek, coupled with incoming competition, hints that enthusiasm is not yet strong enough to sustain an aggressive expanded universe. To keep viewers engaged through Mummy 4 and beyond, Universal may need tweaks in tone, marketing and release strategy—doubling down on character‑driven storytelling, clearer connections between entries, and strategic date placement like the new October slot. Domestically, The Mummy’s realistic path is to secure a modestly higher total than The Bone Temple, with global upside dependent on how international markets respond to Cronin’s horror sensibilities and franchise nostalgia.